Atezolizumab,Carboplatin,Etoposide,Tiragolumab
Roche
['atezo']
. presents disappointing sky2 results- adding anti-tigit to pe-atezo 1st line. allowed untreated cns mets. median f/up 14.3mo. 19% baseline cns mets. no pfs benefit hr1.11. os no benefit, hr1.04. no subsets stand out. orrs similar. aes as expected #asco22 
Thoracic Oncologist @royalmarsdenNHS, Professor @ICR_London; Chair @BTOGorg; views are my own. Wear a mask, keep distant, get the vaccine & then a booster!